Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2026-02-10 @ 12:45 PM
Study NCT ID:
NCT06504368
Status:
RECRUITING
Last Update Posted:
2025-11-06
First Post:
2024-06-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors
Sponsor:
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Solid Tumors, Adult | View |
Keywords: